Acylation-stimulating protein (ASP) acts as a paracrine signal to increase triglyceride synthesis in adipocytes. ASP administration results in more rapid postprandial lipid clearance. In mice, C3 (the precursor to ASP) knockout results in ASP deficiency and leads to reduced body fat and leptin levels. The protective potential of ASP deficiency against obesity and involvement of the leptin pathway were examined in ob/ob C3(؊/؊) double knockout mice (2KO). Compared with agematched ob/ob mice, 2KO mice had delayed postprandial triglyceride and fatty acid clearance; associated with decreased body weight (4 -17 weeks age: male: ؊13.7%, female: ؊20.6%, p < 0.0001) and HOMA (homeostasis model assessment) index (؊37.7%), suggesting increased insulin sensitivity. By contrast, food intake in 2KO mice was ؉9.1% higher over ob/ob mice (p < 0.001, 2KO 5.1 ؎ 0.2 g/day, ob/ob 4.5 ؎ 0.2 g/day, wild type 2.6 ؎ 0.1 g/day). The hyperphagia/leanness was balanced by a 28.5% increase in energy expenditure (oxygen consumption: 2KO, 131 ؎ 8.9 ml/h; ob/ob, 102 ؎ 4.5 ml/h; p < 0.01; wild type, 144 ؎ 8.9 ml/h). These results suggest that the ASP regulation of energy storage may influence energy expenditure and dynamic metabolic balance.Acylation-stimulating protein (ASP) 1 is an adipocyte-derived protein that has potent anabolic effects on human adipose tissue for both glucose uptake and non-esterified fatty acid (NEFA) storage (1, 2). This occurs via translocation of glucose transporters (GLUT1, GLUT3, and GLUT4) from intracellular sites to the cell surface (3, 4) and an increase in diacylglycerol acyltransferase (DGAT) activity (2). These effects appear to be mediated through specific cell surface binding (6, 7), resulting in activation of a signaling pathway that includes protein kinase C (8). In addition, ASP has been shown to inhibit hormone-sensitive lipase in adipocytes, independently and additively to insulin (9). There is a differentiation-dependent increase in ASP binding and ASP response in adipocytes (1). The major site of action of ASP is adipocytes, as determined by competitive binding, stimulation of triglyceride synthesis, enhanced glucose transport, and transporter translocation (6).ASP is identical to C3adesArg, a cleavage product of complement C3. Cleavage of complement C3 is mediated through the alternate complement pathway via the interaction of C3, factor B, and adipsin that generates C3a. Rapid cleavage of the Cterminal arginine of C3a by carboxypeptidase N generates ASP (10). Adipocytes are one of the few cells capable of producing all three factors (factor B, adipsin, and C3) that are required for the production of ASP (11). ASP production increases consequent to adipocyte differentiation (13), and plasma ASP levels are elevated in obesity (14, 15). Chylomicrons in vitro stimulate ASP production by adipocytes (16,17). In vivo arterial-venous gradients across a subcutaneous adipose tissue bed in humans demonstrate direct postprandial production of ASP (18). The postprandial increase in ASP is adipose tissue specifi...